IL33 and cancer: Continuous IL-33-driven stimulation of Tregs shapes a tumor-promoting immune environment associated with chronic inflammation in the murine skin, and an increase in IL-33 expression and Treg accumulation are observed in the perilesional skin of patients with cancer-prone chronic inflammation (178).